{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:26:27Z","timestamp":1780410387085,"version":"3.54.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:00:00Z","timestamp":1622246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T00:00:00Z","timestamp":1622246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Sinonasal Undifferentiated Carcinoma (SNUC) is a rare and aggressive skull base tumor with poor survival and limited treatment options. To date, targeted sequencing studies have identified <jats:italic>IDH2<\/jats:italic> and <jats:italic>SMARCB1<\/jats:italic> as potential driver alterations, but the molecular alterations found in <jats:italic>SMARCB1<\/jats:italic> wild type tumors are unknown.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We evaluated survival outcomes in a cohort of 46 SNUC patients treated at an NCI designated cancer center and identify clinical and disease variables associated with survival on Kaplan-Meier and Cox multivariate survival analysis. We performed exome sequencing to characterize a series of SNUC tumors (<jats:italic>n<\/jats:italic>\u2009=\u20095) and cell line (MDA8788\u20136) to identify high confidence mutations, copy number alterations, microsatellite instability, and fusions. Knockdown studies using siRNA were utilized for validation of a novel <jats:italic>PGAP3-SRPK1<\/jats:italic> gene fusion.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall survival analysis revealed no significant difference in outcomes between patients treated with surgery +\/\u2212 CRT and CRT alone. Tobacco use was the only significant predictor of survival. We also confirmed previously published findings on <jats:italic>IDH<\/jats:italic> and <jats:italic>SMARC<\/jats:italic> family mutations and identified novel recurrent aberrations in the <jats:italic>JAK\/STAT<\/jats:italic> and <jats:italic>PI3K<\/jats:italic> pathways. We also validated a novel <jats:italic>PGAP3<\/jats:italic>-<jats:italic>SRPK1<\/jats:italic> gene fusion in the SNUC cell line, and show that knockdown of the fusion is negatively associated with <jats:italic>EGFR<\/jats:italic>, <jats:italic>E2F<\/jats:italic> and <jats:italic>MYC<\/jats:italic> signaling.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Collectively, these data demonstrate recurrent alterations in the <jats:italic>SWI\/SNF<\/jats:italic> family as well as <jats:italic>IDH, JAK\/STAT, and PI3K pathways<\/jats:italic> and discover a novel fusion gene (<jats:italic>PGAP3-SRPK1<\/jats:italic>). These data aim to improve understanding of possible driver mutations and guide future therapeutic strategies for this disease.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-021-08370-x","type":"journal-article","created":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T12:03:39Z","timestamp":1622289819000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Genetic analysis of sinonasal undifferentiated carcinoma discovers recurrent SWI\/SNF alterations and a novel PGAP3-SRPK1 fusion gene"],"prefix":"10.1186","volume":"21","author":[{"given":"Molly E.","family":"Heft Neal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Birkeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apurva D.","family":"Bhangale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan K.","family":"Foltin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany M.","family":"Jewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan L.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Pinatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan B.","family":"McHugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawence","family":"Marentette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin L.","family":"McKean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Chad","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,29]]},"reference":[{"issue":"2","key":"8370_CR1","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1055\/s-0034-1390016","volume":"76","author":"KJ Chambers","year":"2015","unstructured":"Chambers KJ, Lehmann AE, Remenschneider A, Dedmon M, Meier J, Gray ST, et al. Incidence and survival patterns of sinonasal undifferentiated carcinoma in the United States. J Neurol Surg B Skull Base. 2015;76(2):94\u2013100. https:\/\/doi.org\/10.1055\/s-0034-1390016 PubMed PMID: 25844294; PMCID: 4375051.","journal-title":"J Neurol Surg B Skull Base"},{"issue":"4","key":"8370_CR2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.5812\/ircmj.2209","volume":"15","author":"MJ Ashraf","year":"2013","unstructured":"Ashraf MJ, Azarpira N, Khademi B, Abedi E, Hakimzadeh A, Valibeigi B. Extramedullary plasmacytoma of the nasal cavity report of three cases with review of the literature. Iran Red Crescent Med J. 2013;15(4):363\u20136. https:\/\/doi.org\/10.5812\/ircmj.2209 Epub 2013\/10\/02. PubMed PMID: 24083014; PMCID: PMC3785915.","journal-title":"Iran Red Crescent Med J"},{"issue":"1","key":"8370_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s12105-009-0158-6","volume":"4","author":"JA Bridge","year":"2010","unstructured":"Bridge JA, Bowen JM, Smith RB. The small round blue cell tumors of the sinonasal area. Head Neck Pathol. 2010;4(1):84\u201393. https:\/\/doi.org\/10.1007\/s12105-009-0158-6 Epub 2010\/03\/20. PubMed PMID: 20237994; PMCID: PMC2825526.","journal-title":"Head Neck Pathol"},{"issue":"1","key":"8370_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/hed.23267","volume":"36","author":"A Gelbard","year":"2014","unstructured":"Gelbard A, Hale KS, Takahashi Y, Davies M, Kupferman ME, El-Naggar AK, et al. Molecular profiling of sinonasal undifferentiated carcinoma. Head Neck. 2014;36(1):15\u201321. https:\/\/doi.org\/10.1002\/hed.23267 PubMed PMID: 23633104; PMCID: 3874284.","journal-title":"Head Neck"},{"issue":"2","key":"8370_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1055\/s-0029-1236165","volume":"20","author":"EM Lin","year":"2010","unstructured":"Lin EM, Sparano A, Spalding A, Eisbruch A, Worden FP, Heth J, et al. Sinonasal undifferentiated carcinoma: a 13-year experience at a single institution. Skull Base. 2010;20(2):61\u20137. https:\/\/doi.org\/10.1055\/s-0029-1236165 Epub 2010\/09\/03. PubMed PMID: 20808529; PMCID: PMC2853070.","journal-title":"Skull Base"},{"issue":"1","key":"8370_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/01.coc.0000189691.04140.02","volume":"29","author":"WM Mendenhall","year":"2006","unstructured":"Mendenhall WM, Mendenhall CM, Riggs CE Jr, Villaret DB, Mendenhall NP. Sinonasal undifferentiated carcinoma. Am J Clin Oncol. 2006;29(1):27\u201331. https:\/\/doi.org\/10.1097\/01.coc.0000189691.04140.02 Epub 2006\/02\/08. PubMed PMID: 16462499.","journal-title":"Am J Clin Oncol"},{"issue":"8","key":"8370_CR7","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1097\/00005537-200008000-00007","volume":"110","author":"RC Miyamoto","year":"2000","unstructured":"Miyamoto RC, Gleich LL, Biddinger PW, Gluckman JL. Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis. Laryngoscope. 2000;110(8):1262\u20135. https:\/\/doi.org\/10.1097\/00005537-200008000-00007 Epub 2000\/08\/15. PubMed PMID: 10942123.","journal-title":"Laryngoscope"},{"issue":"8 Pt 1","key":"8370_CR8","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1097\/00005537-200208000-00023","volume":"112","author":"PY Musy","year":"2002","unstructured":"Musy PY, Reibel JF, Levine PA. Sinonasal undifferentiated carcinoma: the search for a better outcome. Laryngoscope. 2002;112(8 Pt 1):1450\u20135. https:\/\/doi.org\/10.1097\/00005537-200208000-00023 Epub 2002\/08\/13. PubMed PMID: 12172261.","journal-title":"Laryngoscope"},{"issue":"5","key":"8370_CR9","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/hed.10396","volume":"26","author":"D Rischin","year":"2004","unstructured":"Rischin D, Porceddu S, Peters L, Martin J, Corry J, Weih L. Promising results with chemoradiation in patients with sinonasal undifferentiated carcinoma. Head Neck. 2004;26(5):435\u201341. https:\/\/doi.org\/10.1002\/hed.10396 Epub 2004\/05\/04. PubMed PMID: 15122660.","journal-title":"Head Neck."},{"issue":"3","key":"8370_CR10","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/hed.23606","volume":"37","author":"ST Gray","year":"2015","unstructured":"Gray ST, Herr MW, Sethi RK, Diercks G, Lee L, Curry W, et al. Treatment outcomes and prognostic factors, including human papillomavirus, for sinonasal undifferentiated carcinoma: a retrospective review. Head Neck. 2015;37(3):366\u201374. https:\/\/doi.org\/10.1002\/hed.23606 PubMed PMID: 24421248.","journal-title":"Head Neck"},{"key":"8370_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.oraloncology.2017.10.008","volume":"75","author":"GB Morand","year":"2017","unstructured":"Morand GB, Anderegg N, Vital D, Ikenberg K, Huber GF, Soyka MB, et al. Outcome by treatment modality in sinonasal undifferentiated carcinoma (SNUC): a case-series, systematic review and meta-analysis. Oral Oncol. 2017;75:28\u201334. https:\/\/doi.org\/10.1016\/j.oraloncology.2017.10.008 PubMed PMID: 29224819.","journal-title":"Oral Oncol"},{"issue":"9","key":"8370_CR12","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1002\/hed.24834","volume":"39","author":"ME Gamez","year":"2017","unstructured":"Gamez ME, Lal D, Halyard MY, Wong WW, Vargas C, Ma D, et al. Outcomes and patterns of failure for sinonasal undifferentiated carcinoma (SNUC): the Mayo Clinic experience. Head Neck. 2017;39(9):1819\u201324. https:\/\/doi.org\/10.1002\/hed.24834 PubMed PMID: 28561906.","journal-title":"Head Neck"},{"issue":"1","key":"8370_CR13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1177\/0194599816670146","volume":"156","author":"P Kuo","year":"2017","unstructured":"Kuo P, Manes RP, Schwam ZG, Judson BL. Survival outcomes for combined modality therapy for Sinonasal undifferentiated carcinoma. Otolaryngol Head Neck Surg. 2017;156(1):132\u20136. https:\/\/doi.org\/10.1177\/0194599816670146 PubMed PMID: 27703092.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"6","key":"8370_CR14","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1200\/jco.18.00353","volume":"37","author":"M Amit","year":"2019","unstructured":"Amit M, Abdelmeguid AS, Watcherporn T, Takahashi H, Tam S, Bell D, et al. Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma. J Clin Oncol. 2019;37(6):504\u201312. https:\/\/doi.org\/10.1200\/jco.18.00353 Epub 2019\/01\/08. PubMed PMID: 30615549; PMCID: PMC6380524.","journal-title":"J Clin Oncol"},{"issue":"4","key":"8370_CR15","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/path.4915","volume":"242","author":"S Dogan","year":"2017","unstructured":"Dogan S, Chute DJ, Xu B, Ptashkin RN, Chandramohan R, Casanova-Murphy J, et al. Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas. J Pathol. 2017;242(4):400\u20138. https:\/\/doi.org\/10.1002\/path.4915 PubMed PMID: 28493366; PMCID: 5639875.","journal-title":"J Pathol"},{"issue":"4","key":"8370_CR16","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/PAS.0000000000000797","volume":"41","author":"A Agaimy","year":"2017","unstructured":"Agaimy A, Hartmann A, Antonescu CR, Chiosea SI, El-Mofty SK, Geddert H, et al. SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: a series of 39 cases expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity. Am J Surg Pathol. 2017;41(4):458\u201371. https:\/\/doi.org\/10.1097\/PAS.0000000000000797 PubMed PMID: 28291122; PMCID: 5354087.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"8370_CR17","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/modpathol.2016.239","volume":"30","author":"VY Jo","year":"2017","unstructured":"Jo VY, Chau NG, Hornick JL, Krane JF, Sholl LM. Recurrent IDH2 R172X mutations in sinonasal undifferentiated carcinoma. Mod Pathol. 2017;30(5):650\u20139. https:\/\/doi.org\/10.1038\/modpathol.2016.239 Epub 2017\/01\/14. PubMed PMID: 28084339.","journal-title":"Mod Pathol"},{"issue":"Suppl 1","key":"8370_CR18","doi-asserted-by":"publisher","first-page":"E1926","DOI":"10.1002\/hed.24350","volume":"38","author":"Y Takahashi","year":"2016","unstructured":"Takahashi Y, Lee J, Pickering C, Bell D, Jiffar TW, Myers JN, et al. Human epidermal growth factor receptor 2\/neu as a novel therapeutic target in sinonasal undifferentiated carcinoma. Head Neck. 2016;38(Suppl 1):E1926\u201334. https:\/\/doi.org\/10.1002\/hed.24350 PubMed PMID: 26752332.","journal-title":"Head Neck"},{"issue":"9","key":"8370_CR19","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1002\/hed.23443","volume":"36","author":"A Schrock","year":"2014","unstructured":"Schrock A, Goke F, Wagner P, Bode M, Franzen A, Huss S, et al. Fibroblast growth factor receptor-1 as a potential therapeutic target in sinonasal cancer. Head Neck. 2014;36(9):1253\u20137. https:\/\/doi.org\/10.1002\/hed.23443 PubMed PMID: 23913758.","journal-title":"Head Neck"},{"issue":"1","key":"8370_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/0194599819889976","volume":"162","author":"AG Shuman","year":"2020","unstructured":"Shuman AG, Gornick MC, Brummel C, Kent M, Spector-Bagdady K, Biddle E, et al. Patient and provider perspectives regarding enrollment in head and neck cancer research. Otolaryngol Head Neck Surg. 2020;162(1):73\u20138. https:\/\/doi.org\/10.1177\/0194599819889976 Epub 2019\/12\/11. PubMed PMID: 31818193; PMCID: PMC6946860.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"22","key":"8370_CR21","doi-asserted-by":"publisher","first-page":"6178","DOI":"10.1158\/1078-0432.Ccr-12-1876","volume":"18","author":"Y Takahashi","year":"2012","unstructured":"Takahashi Y, Kupferman ME, Bell D, Jiffar T, Lee JG, Xie TX, et al. Establishment and characterization of novel cell lines from sinonasal undifferentiated carcinoma. Clin Cancer Res. 2012;18(22):6178\u201387. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-12-1876 Epub 2012\/10\/04. PubMed PMID: 23032744; PMCID: PMC3513379.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"8370_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/hed.21198","volume":"32","author":"JC Brenner","year":"2010","unstructured":"Brenner JC, Graham MP, Kumar B, Saunders LM, Kupfer R, Lyons RH, et al. Genotyping of 73 UM-SCC head and neck squamous cell carcinoma cell lines. Head Neck. 2010;32(4):417\u201326. https:\/\/doi.org\/10.1002\/hed.21198 Epub 2009\/09\/18. PubMed PMID: 19760794; PMCID: PMC3292176.","journal-title":"Head Neck"},{"issue":"4","key":"8370_CR23","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1055\/s-0037-1601320","volume":"78","author":"AC Birkeland","year":"2017","unstructured":"Birkeland AC, Burgin SJ, Yanik M, Scott MV, Bradford CR, McHugh JB, et al. Pathogenetic Analysis of Sinonasal Teratocarcinosarcomas Reveal Actionable beta-catenin Overexpression and a beta-catenin Mutation. J Neurol Surg B Skull Base. 2017;78(4):346\u201352. https:\/\/doi.org\/10.1055\/s-0037-1601320 Epub 2017\/07\/21. PubMed PMID: 28725522; PMCID: PMC5515660.","journal-title":"J Neurol Surg B Skull Base"},{"issue":"5","key":"8370_CR24","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1177\/0194599818774004","volume":"159","author":"J Smith","year":"2018","unstructured":"Smith J, Kulkarni A, Birkeland AC, McHugh JB, Brenner JC. Whole-exome sequencing of sinonasal small cell carcinoma arising within a papillary schneiderian carcinoma in situ. Otolaryngol Head Neck Surg. 2018;159(5):859\u201365. https:\/\/doi.org\/10.1177\/0194599818774004 PubMed PMID: 29734873; PMCID: PMC6212311.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"8370_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.oraloncology.2017.02.025","volume":"68","author":"AC Birkeland","year":"2017","unstructured":"Birkeland AC, Foltin SK, Michmerhuizen NL, Hoesli RC, Rosko AJ, Byrd S, et al. Correlation of Crtc1\/3-Maml2 fusion status, grade and survival in mucoepidermoid carcinoma. Oral Oncol. 2017;68:5\u20138. https:\/\/doi.org\/10.1016\/j.oraloncology.2017.02.025 PubMed PMID: 28438292; PMCID: 5433350.","journal-title":"Oral Oncol"},{"issue":"9","key":"8370_CR26","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1002\/hed.25803","volume":"41","author":"JE Mann","year":"2019","unstructured":"Mann JE, Kulkarni A, Birkeland AC, Kafelghazal J, Eisenberg J, Jewell BM, et al. The molecular landscape of the University of Michigan laryngeal squamous cell carcinoma cell line panel. Head Neck. 2019;41(9):3114\u201324. 31090975. https:\/\/doi.org\/10.1002\/hed.25803.","journal-title":"Head Neck"},{"issue":"7","key":"8370_CR27","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/bioinformatics\/btt755","volume":"30","author":"B Niu","year":"2014","unstructured":"Niu B, Ye K, Zhang Q, Lu C, Xie M, McLellan MD, et al. MSIsensor: microsatellite instability detection using paired tumor-normal sequence data. Bioinformatics. 2014;30(7):1015\u20136. https:\/\/doi.org\/10.1093\/bioinformatics\/btt755 Epub 2013\/12\/29. PubMed PMID: 24371154; PMCID: PMC3967115.","journal-title":"Bioinformatics"},{"key":"8370_CR28","doi-asserted-by":"publisher","unstructured":"Michmerhuizen NL, Leonard E, Matovina C, Harris M, Herbst G, Kulkarni A, Zhai J, Jiang H, Carey TE, Brenner JC. Rationale for Using Irreversible epidermal growth factor receptor inhibitors in combination with Phosphatidylinositol 3-Kinase inhibitors for advanced Head and Neck Squamous Cell Carcinoma. Mol Pharmacol 2019;95(5):528\u2013536. doi: https:\/\/doi.org\/10.1124\/mol.118.115162. Epub 2019\/03\/13. PubMed PMID: 30858165; PMCID: PMC6442321.","DOI":"10.1124\/mol.118.115162"},{"key":"8370_CR29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.oraloncology.2018.10.031","volume":"87","author":"ML Ludwig","year":"2018","unstructured":"Ludwig ML, Kulkarni A, Birkeland AC, Michmerhuizen NL, Foltin SK, Mann JE, et al. The genomic landscape of UM-SCC oral cavity squamous cell carcinoma cell lines. Oral Oncol. 2018;87:144\u201351. https:\/\/doi.org\/10.1016\/j.oraloncology.2018.10.031 Epub 2018\/12\/12. PubMed PMID: 30527230.","journal-title":"Oral Oncol"},{"issue":"4","key":"8370_CR30","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method. Methods. 2001;25(4):402\u20138. https:\/\/doi.org\/10.1006\/meth.2001.1262 Epub 2002\/02\/16. PubMed PMID: 11846609.","journal-title":"Methods"},{"key":"8370_CR31","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.3389\/fimmu.2018.02657","volume":"9","author":"C Cui","year":"2018","unstructured":"Cui C, Su M, Lin Y, Lai L. A CD300c-Fc Fusion Protein Inhibits T Cell Immunity. Front Immunol. 2018;9:2657. https:\/\/doi.org\/10.3389\/fimmu.2018.02657 Epub 2018\/12\/01. PubMed PMID: 30498497; PMCID: PMC6249344.","journal-title":"Front Immunol"},{"issue":"23","key":"8370_CR32","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1080\/15384101.2016.1234551","volume":"15","author":"J Hsu","year":"2016","unstructured":"Hsu J, Sage J. Novel functions for the transcription factor E2F4 in development and disease. Cell Cycle. 2016;15(23):3183\u201390. https:\/\/doi.org\/10.1080\/15384101.2016.1234551 Epub 2016\/10\/19. PubMed PMID: 27753528; PMCID: PMC5176148.","journal-title":"Cell Cycle"},{"key":"8370_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/lctt.S124483","volume":"9","author":"E Mastrangelo","year":"2018","unstructured":"Mastrangelo E, Milani M. Role and inhibition of GLI1 protein in cancer. Lung Cancer. 2018;9:35\u201343. https:\/\/doi.org\/10.2147\/lctt.S124483 Epub 2018\/04\/10. PubMed PMID: 29628779; PMCID: PMC5877502.","journal-title":"Lung Cancer"},{"issue":"17","key":"8370_CR34","doi-asserted-by":"publisher","first-page":"5318","DOI":"10.1158\/1078-0432.Ccr-07-5136","volume":"14","author":"S Shangary","year":"2008","unstructured":"Shangary S, Wang S. Targeting the MDM2-p53 interaction for cancer therapy. Clin Cancer Res. 2008;14(17):5318\u201324. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-07-5136 Epub 2008\/09\/04. PubMed PMID: 18765522; PMCID: PMC2676446.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"8370_CR35","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00432-018-2625-5","volume":"144","author":"A Abudureheman","year":"2018","unstructured":"Abudureheman A, Ainiwaer J, Hou Z, Niyaz M, Turghun A, Hasim A, et al. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol. 2018;144(6):1025\u201335. https:\/\/doi.org\/10.1007\/s00432-018-2625-5 Epub 2018\/03\/14. PubMed PMID: 29532228; PMCID: PMC5948284.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"7","key":"8370_CR36","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1002\/prot.24065","volume":"80","author":"D Xu","year":"2012","unstructured":"Xu D, Zhang Y. Ab initio protein structure assembly using continuous structure fragments and optimized knowledge-based force field. Proteins. 2012;80(7):1715\u201335. https:\/\/doi.org\/10.1002\/prot.24065 Epub 2012\/03\/14. PubMed PMID: 22411565; PMCID: PMC3370074.","journal-title":"Proteins"},{"issue":"2","key":"8370_CR37","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/prot.24179","volume":"81","author":"D Xu","year":"2013","unstructured":"Xu D, Zhang Y. Toward optimal fragment generations for ab initio protein structure assembly. Proteins. 2013;81(2):229\u201339. https:\/\/doi.org\/10.1002\/prot.24179 Epub 2012\/09\/14. PubMed PMID: 22972754; PMCID: PMC3551984.","journal-title":"Proteins"},{"issue":"4","key":"8370_CR38","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/path.4846","volume":"241","author":"N Bullock","year":"2017","unstructured":"Bullock N, Oltean S. The many faces of SRPK1. J Pathol. 2017;241(4):437\u201340. https:\/\/doi.org\/10.1002\/path.4846 Epub 2016\/11\/20. PubMed PMID: 27859253; PMCID: PMC5324686.","journal-title":"J Pathol"},{"key":"8370_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.humpath.2020.09.013","volume":"106","author":"S Dogan","year":"2020","unstructured":"Dogan S, Frosina D, Geronimo JA, Hernandez E, Mohanty A, Bale T, et al. Molecular epidemiology of IDH2 hotspot mutations in cancer and immunohistochemical detection of R172K, R172G, and R172M variants. Hum Pathol. 2020;106:45\u201353. https:\/\/doi.org\/10.1016\/j.humpath.2020.09.013 Epub 2020\/10\/06. PubMed PMID: 33017591; PMCID: PMC7721993.","journal-title":"Hum Pathol"},{"key":"8370_CR40","doi-asserted-by":"publisher","unstructured":"Ayyanar P, Mishra P, Preetam C, Adhya AK. SMARCB1\/INI1 deficient Sino-nasal carcinoma: extending the Histomorphological features. Head Neck Pathol. 2020. https:\/\/doi.org\/10.1007\/s12105-020-01246-9 Epub 2020\/11\/04. PubMed PMID: 33141418.","DOI":"10.1007\/s12105-020-01246-9"},{"issue":"6","key":"8370_CR41","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1055\/s-0039-1693659","volume":"81","author":"C Chitguppi","year":"2020","unstructured":"Chitguppi C, Rabinowitz MR, Johnson J, Bar-Ad V, Fastenberg JH, Molligan J, et al. Loss of SMARCB1 Expression Confers Poor Prognosis to Sinonasal Undifferentiated Carcinoma. J Neurol Surg B Skull Base. 2020;81(6):610\u20139. https:\/\/doi.org\/10.1055\/s-0039-1693659 Epub 2021\/01\/01. PubMed PMID: 33381364; PMCID: PMC7755502.","journal-title":"J Neurol Surg B Skull Base"},{"key":"8370_CR42","doi-asserted-by":"publisher","first-page":"14648","DOI":"10.1038\/ncomms14648","volume":"8","author":"BH Alver","year":"2017","unstructured":"Alver BH, Kim KH, Lu P, Wang X, Manchester HE, Wang W, et al. The SWI\/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers. Nat Commun. 2017;8:14648. https:\/\/doi.org\/10.1038\/ncomms14648 PubMed PMID: 28262751; PMCID: 5343482.","journal-title":"Nat Commun"},{"issue":"4","key":"8370_CR43","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/cas.13173","volume":"108","author":"K Kohashi","year":"2017","unstructured":"Kohashi K, Oda Y. Oncogenic roles of SMARCB1\/INI1 and its deficient tumors. Cancer Sci. 2017;108(4):547\u201352. https:\/\/doi.org\/10.1111\/cas.13173 PubMed PMID: 28109176; PMCID: 5406539.","journal-title":"Cancer Sci"},{"issue":"46","key":"8370_CR44","doi-asserted-by":"publisher","first-page":"12249","DOI":"10.1073\/pnas.1703966114","volume":"114","author":"T Januario","year":"2017","unstructured":"Januario T, Ye X, Bainer R, Alicke B, Smith T, Haley B, et al. PRC2-mediated repression of SMARCA2 predicts EZH2 inhibitor activity in SWI\/SNF mutant tumors. Proc Nat Acad Sci USA. 2017;114(46):12249\u201354. https:\/\/doi.org\/10.1073\/pnas.1703966114 PubMed PMID: 29087303; PMCID: 5699030.","journal-title":"Proc Nat Acad Sci USA"},{"issue":"7","key":"8370_CR45","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/hed.21061","volume":"31","author":"RD Chernock","year":"2009","unstructured":"Chernock RD, Perry A, Pfeifer JD, Holden JA, Lewis JS Jr. Receptor tyrosine kinases in sinonasal undifferentiated carcinomas--evaluation for EGFR, c-KIT, and HER2\/neu expression. Head Neck. 2009;31(7):919\u201327. https:\/\/doi.org\/10.1002\/hed.21061 PubMed PMID: 19283847.","journal-title":"Head Neck"},{"issue":"12","key":"8370_CR46","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1111\/cas.13839","volume":"109","author":"MJ Ban","year":"2018","unstructured":"Ban MJ, Byeon HK, Yang YJ, An S, Kim JW, Kim JH, et al. Fibroblast growth factor receptor 3-mediated reactivation of ERK signaling promotes head and neck squamous cancer cell insensitivity to MEK inhibition. Cancer Sci. 2018;109(12):3816\u201325. https:\/\/doi.org\/10.1111\/cas.13839 Epub 2018\/10\/22. PubMed PMID: 30343534; PMCID: PMC6272115.","journal-title":"Cancer Sci"},{"issue":"38","key":"8370_CR47","doi-asserted-by":"publisher","first-page":"25148","DOI":"10.18632\/oncotarget.25358","volume":"9","author":"SC McDermott","year":"2018","unstructured":"McDermott SC, Rodriguez-Ramirez C, McDermott SP, Wicha MS, Nor JE. FGFR signaling regulates resistance of head and neck cancer stem cells to cisplatin. Oncotarget. 2018;9(38):25148\u201365. https:\/\/doi.org\/10.18632\/oncotarget.25358 Epub 2018\/06\/05. PubMed PMID: 29861860; PMCID: PMC5982758.","journal-title":"Oncotarget"},{"issue":"7","key":"8370_CR48","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/lary.23266","volume":"122","author":"L Sweeny","year":"2012","unstructured":"Sweeny L, Liu Z, Lancaster W, Hart J, Hartman YE, Rosenthal EL. Inhibition of fibroblasts reduced head and neck cancer growth by targeting fibroblast growth factor receptor. Laryngoscope. 2012;122(7):1539\u201344. https:\/\/doi.org\/10.1002\/lary.23266 Epub 2012\/03\/31. PubMed PMID: 22460537; PMCID: PMC3447628.","journal-title":"Laryngoscope"},{"key":"8370_CR49","doi-asserted-by":"publisher","unstructured":"Takahashi Y, Gleber-Netto FO, Bell D, Roberts D, Xie TX, Abdelmeguid AS, Pickering C, Myers JN, Hanna EY. Identification of markers predictive for response to induction chemotherapy in patients with sinonasal undifferentiated carcinoma. Oral Oncol 2019;97:56\u201361. doi: https:\/\/doi.org\/10.1016\/j.oraloncology.2019.07.028. Epub 2019\/08\/20. PubMed PMID: 31421472.","DOI":"10.1016\/j.oraloncology.2019.07.028"},{"key":"8370_CR50","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.2147\/OTT.S161835","volume":"11","author":"Y Yao","year":"2018","unstructured":"Yao Y, Li Q, Wang H. MiR-216b suppresses colorectal cancer proliferation, migration, and invasion by targeting SRPK1. OncoTargets Ther. 2018;11:1671\u201381. https:\/\/doi.org\/10.2147\/OTT.S161835 PubMed PMID: 29615842; PMCID: 5870636.","journal-title":"OncoTargets Ther"},{"issue":"9","key":"8370_CR51","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3727\/096504018X15180508535835","volume":"26","author":"Q Li","year":"2018","unstructured":"Li Q, Wang G, Wang H. MiR-126 functions as a tumor suppressor by targeting SRPK1 in human gastric cancer. Oncol Res. 2018;26(9):1345\u201353. https:\/\/doi.org\/10.3727\/096504018X15180508535835. PubMed PMID: 29510776.","journal-title":"Oncol Res"},{"issue":"42","key":"8370_CR52","doi-asserted-by":"publisher","first-page":"72157","DOI":"10.18632\/oncotarget.20048","volume":"8","author":"H Wang","year":"2017","unstructured":"Wang H, Wang C, Tian W, Yao Y. The crucial role of SRPK1 in IGF-1-induced EMT of human gastric cancer. Oncotarget. 2017;8(42):72157\u201366. https:\/\/doi.org\/10.18632\/oncotarget.20048 PubMed PMID: 29069776; PMCID: 5641119.","journal-title":"Oncotarget"},{"issue":"37","key":"8370_CR53","doi-asserted-by":"publisher","first-page":"61944","DOI":"10.18632\/oncotarget.18734","volume":"8","author":"X Xu","year":"2017","unstructured":"Xu X, Wei Y, Wang S, Luo M, Zeng H. Serine-arginine protein kinase 1 (SRPK1) is elevated in gastric cancer and plays oncogenic functions. Oncotarget. 2017;8(37):61944\u201357. https:\/\/doi.org\/10.18632\/oncotarget.18734 PubMed PMID: 28977917; PMCID: 5617477.","journal-title":"Oncotarget"},{"issue":"5894","key":"8370_CR54","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1126\/science.1156725","volume":"321","author":"H Li","year":"2008","unstructured":"Li H, Wang J, Mor G, Sklar J. A neoplastic gene fusion mimics trans-splicing of RNAs in normal human cells. Science. 2008;321(5894):1357\u201361. https:\/\/doi.org\/10.1126\/science.1156725 Epub 2008\/09\/06. PubMed PMID: 18772439.","journal-title":"Science"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08370-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08370-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08370-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T12:04:42Z","timestamp":1622289882000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08370-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,29]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8370"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08370-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,29]]},"assertion":[{"value":"24 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a retrospective data review study without direct involvement of human subjects and as such informed consent was waived by the University of Michigan Institutional Review Board (ID#: HUM00080561 and HUM00085888) to obtain surplus tissues from Department of Pathology archives for study. All methods were carried out in accordance with relevant guidelines and regulations from the University of Michigan ethics committee. All experimental protocols were approved by University of Michigan ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"636"}}